Literature DB >> 10080559

Phenomenology of mania: evidence for distinct depressed, dysphoric, and euphoric presentations.

S C Dilsaver1, Y R Chen, A M Shoaib, A C Swann.   

Abstract

OBJECTIVE: A substantial number of manic episodes include conspicuous depressive symptoms. Manic episodes have been clinically classified a posteriori using preset criteria. The aim of this study was to investigate the possibility that there might be a natural division of manic episodes into clinical types.
METHOD: One hundred and five inpatients met Research Diagnostic Criteria and DSM-III-R criteria for manic episodes and were rated before institution of pharmacological treatment. The authors conducted a factor analysis of 37 behavior rating items from the Schedule for Affective Disorders and Schizophrenia. The resulting factors were used as independent variables in a cluster analysis of the patients.
RESULTS: This analysis revealed four factors corresponding to manic activation, depressed state, sleep disturbance, and irritability/paranoia. Cluster analysis separated the patients into two groups. One included patients with major depressive disorder and mania. Blind, a priori clinical classification into classic and mixed mania (mania plus depression) showed that all of the patients in the depressed cluster, and about 40% of those in the nondepressed cluster, were in a mixed state according to clinical criteria. Comparison of the clinically mixed and nonmixed patients in the nondepressed cluster revealed that the mixed patients in that cluster had higher scores for items related to anger, worry, dysphoria, and irritability.
CONCLUSIONS: These data suggest that manic episodes can be naturalistically classified as classic (predominately euphoric), dysphoric, or depressed.

Entities:  

Mesh:

Year:  1999        PMID: 10080559     DOI: 10.1176/ajp.156.3.426

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  19 in total

Review 1.  A review of postpartum psychosis.

Authors:  Dorothy Sit; Anthony J Rothschild; Katherine L Wisner
Journal:  J Womens Health (Larchmt)       Date:  2006-05       Impact factor: 2.681

2.  Toward the delineation of mania subtypes in the French National EPIMAN-II Mille Cohort. Comparisons with prior cluster analytic investigations.

Authors:  Jean-Michel Azorin; Arthur Kaladjian; Marc Adida; Elie Hantouche; Ahcene Hameg; Sylvie Lancrenon; Hagop Souren Akiskal
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-20       Impact factor: 5.270

3.  Testing atypical depression definitions.

Authors:  Franco Benazzi
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035

4.  Manic symptoms and impulsivity during bipolar depressive episodes.

Authors:  Alan C Swann; F Gerard Moeller; Joel L Steinberg; Laurie Schneider; Ernest S Barratt; Donald M Dougherty
Journal:  Bipolar Disord       Date:  2007-05       Impact factor: 6.744

5.  Phenomenology of mania - a factor analysis approach.

Authors:  R Kumar; B N Sinha; N Chakrabarti; V K Sinha
Journal:  Indian J Psychiatry       Date:  2001-01       Impact factor: 1.759

6.  Depressive and manic symptoms are not opposite poles in bipolar disorder.

Authors:  S L Johnson; R Morriss; J Scott; E Paykel; P Kinderman; R Kolamunnage-Dona; R P Bentall
Journal:  Acta Psychiatr Scand       Date:  2010-09-05       Impact factor: 6.392

Review 7.  Women and bipolar disorder across the life span.

Authors:  Dorothy Sit
Journal:  J Am Med Womens Assoc (1972)       Date:  2004

8.  The structure of lifetime manic-hypomanic spectrum.

Authors:  G B Cassano; M Mula; P Rucci; M Miniati; E Frank; D J Kupfer; A Oppo; S Calugi; L Maggi; R Gibbons; A Fagiolini
Journal:  J Affect Disord       Date:  2008-06-09       Impact factor: 4.839

Review 9.  Bipolar II disorder : epidemiology, diagnosis and management.

Authors:  Franco Benazzi
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 10.  Epidemiology, diagnosis and management of mixed mania.

Authors:  Ana González-Pinto; Ana Aldama; Fernando Mosquera; Cristina González Gómez
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.